Distribuzione geografica
Continente #
EU - Europa 58
NA - Nord America 10
AS - Asia 1
Totale 69
Nazione #
IT - Italia 52
US - Stati Uniti d'America 6
CA - Canada 3
CZ - Repubblica Ceca 2
DE - Germania 2
CR - Costa Rica 1
FR - Francia 1
IE - Irlanda 1
VN - Vietnam 1
Totale 69
Città #
Pavia 42
Hamilton 3
Rome 3
Byron 2
Cornaredo 2
Council Bluffs 1
Dossenheim 1
Dublin 1
Fiumicino 1
Ho Chi Minh City 1
Houston 1
Milan 1
Paris 1
Reggio Emilia 1
Rochester 1
San José 1
Varese 1
Weinheim 1
Totale 65
Nome #
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms., file e1f104fa-2275-8c6e-e053-1005fe0aa0dd 7
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene, file e1f104fa-cfd3-8c6e-e053-1005fe0aa0dd 5
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms., file e1f104fd-094f-8c6e-e053-1005fe0aa0dd 5
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders, file e1f104fa-d8fd-8c6e-e053-1005fe0aa0dd 3
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations, file e1f104fa-17c6-8c6e-e053-1005fe0aa0dd 2
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment), file e1f104fa-17ee-8c6e-e053-1005fe0aa0dd 2
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis, file e1f104fa-fe8e-8c6e-e053-1005fe0aa0dd 2
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms, file e1f104fb-c0d7-8c6e-e053-1005fe0aa0dd 2
JAK inhibitors and risk of B-cell lymphomas., file e1f104fc-5977-8c6e-e053-1005fe0aa0dd 2
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results., file e1f104fc-5b05-8c6e-e053-1005fe0aa0dd 2
Facing erythrocytosis: Results of an international physician survey., file e1f104fc-91b0-8c6e-e053-1005fe0aa0dd 2
Clinical significance of somatic mutation in unexplained blood cytopenia, file e1f104fc-91f1-8c6e-e053-1005fe0aa0dd 2
Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver, file fcb01327-ad09-4add-a834-3065a302fe0d 2
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study, file 17a9dc19-f750-4a0a-9dbe-d3ecc3d37b51 1
Long-term follow-up of recovered MPN patients with COVID-19, file 3924682e-55aa-4304-a40b-37eef03f7e32 1
Second versus first wave of COVID-19 in patients with MPN, file 4a8edc54-1f32-4791-b900-334ece3fbefb 1
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis, file 4e575495-1a9a-46b5-95f1-7c549fbb214e 1
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19, file 5099053d-55d9-4cd6-bc39-821299acaadf 1
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients, file 57471d9e-8ea1-493b-9017-91c7a2be6f00 1
Isolated congenital asplenia: An overlooked cause of thrombocytosis, file 6283e6f9-bd4d-4e5a-a66d-2612c412c3fa 1
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms, file 6dbca33f-0a78-4aaf-859e-ecc5382a6457 1
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms, file 8fd2e95d-526c-49c3-815f-936736bfc7e7 1
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms, file 957293fe-f949-4a61-afc0-07aad1e74fba 1
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms, file 99c97210-e509-4866-bcfb-e6958995c82f 1
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms, file 9ce4b871-f316-4522-9fde-568a67d046e4 1
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project, file c6c1c123-82cc-49f9-afef-cf2077d3e4e6 1
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis, file d8032ec1-36b5-4ffe-a2a3-c10d15f2cd99 1
Breakthrough infections in MPN-COVID vaccinated patients, file debeb6e5-e2dc-40c6-880c-dec8a3321cf0 1
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia, file e1f104fa-00cb-8c6e-e053-1005fe0aa0dd 1
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment, file e1f104fa-1371-8c6e-e053-1005fe0aa0dd 1
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients., file e1f104fa-1831-8c6e-e053-1005fe0aa0dd 1
The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms., file e1f104fa-1832-8c6e-e053-1005fe0aa0dd 1
Cardiovascular events and intensity of treatment in polycythemia vera., file e1f104fa-20b8-8c6e-e053-1005fe0aa0dd 1
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study., file e1f104fa-2273-8c6e-e053-1005fe0aa0dd 1
Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm., file e1f104fa-23c7-8c6e-e053-1005fe0aa0dd 1
Development and validation of an International Prognostic Score of thrombosis in WHO-Essential Thrombocythemia (IPSET-thrombosis)., file e1f104fa-2697-8c6e-e053-1005fe0aa0dd 1
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation, file e1f104fa-cf8b-8c6e-e053-1005fe0aa0dd 1
null, file e1f104fc-5b04-8c6e-e053-1005fe0aa0dd 1
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms, file e1f104fc-9052-8c6e-e053-1005fe0aa0dd 1
How I treat essential thrombocythemia., file e1f104fc-edac-8c6e-e053-1005fe0aa0dd 1
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms, file e1f104fd-1594-8c6e-e053-1005fe0aa0dd 1
Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet, file e20f0e5e-6e79-41e7-b6fa-71dc56c61bb3 1
Wandering Spleen: An Unusual Cause of Recurrent Abdominal Pain, file f8898396-97eb-47fb-a35c-4dad87b3df98 1
COVID-19 in Patients with Hematologic Diseases, file fe9240da-c532-4bd8-b9f3-6965779d5908 1
Totale 69
Categoria #
all - tutte 222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 5 0 0 0 0
2020/20215 4 0 0 0 0 0 0 0 1 0 0 0
2022/202345 1 0 1 3 4 2 4 2 2 4 22 0
Totale 69